Equels Thomas K 4
4 · AIM ImmunoTech Inc. · Filed Dec 19, 2024
Insider Transaction Report
Form 4
Equels Thomas K
CEO & President
Transactions
- Purchase
Common Stock
2024-12-18$0.21/sh+22,727$4,682→ 1,680,695 total
4 · AIM ImmunoTech Inc. · Filed Dec 19, 2024
Common Stock